These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2092632)

  • 21. [Toxicity and antimicrobial properties of the new aminoglycoside antibiotic 535].
    Gol'dberg LE; Filippos'iants ST; Malkova IV; Shapovalova SP
    Antibiot Med Biotekhnol; 1985 Oct; 30(10):743-7. PubMed ID: 4091511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides.
    Domenech A; Ribes S; Cabellos C; Taberner F; Tubau F; Domínguez MA; Montero A; Liñares J; Ariza J; Gudiol F
    J Antimicrob Chemother; 2005 Oct; 56(4):709-16. PubMed ID: 16120625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Eremomycin--a new antibiotic from the cyclic glycopeptide group].
    Gauze GF; Brazhnikova MG; Laĭko AV; Sveshnikova MA; Preobrazhenskaia TP
    Antibiot Med Biotekhnol; 1987 Aug; 32(8):571-6. PubMed ID: 3674837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative nephrotoxicity of carboplatin and cisplatin in combination with tobramycin.
    Bregman CL; Williams PD
    Cancer Chemother Pharmacol; 1986; 18(2):117-23. PubMed ID: 3539384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetic study of eremomycin in an experiment].
    Filippos'iants ST; Malkova IV
    Antibiot Med Biotekhnol; 1987 Jul; 32(7):511-6. PubMed ID: 3118795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
    Panda A; Ahuja R; Sastry SS
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibiotic-induced diseases. Aminoglycoside-induced renal lesions].
    Gioannini P
    Minerva Med; 1978 Dec; 69(61):4215-25. PubMed ID: 366465
    [No Abstract]   [Full Text] [Related]  

  • 28. Experimental studies on nephrotoxicity and pharmacokinetics of LY 146032 (daptomycin) in rats.
    Kreft B; de Wit C; Krech R; Marre R; Schulz E; Sack K
    J Antimicrob Chemother; 1990 Apr; 25(4):635-43. PubMed ID: 2161823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glycopeptide antibiotics: eremomycin, vancomycin, and teicoplanin. Comparison of several parameters of pharmacokinetics and antimicrobial activity].
    Filippos'iants ST; Malkova IV; Gol'dberg LE
    Antibiot Khimioter; 1989 Jul; 34(7):523-6. PubMed ID: 2530944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical tobramycin and gentamicin sulfate in the treatment of ocular infections: multicenter study.
    Cagle G; Davis S; Rosenthal A; Smith J
    Curr Eye Res; 1981-1982; 1(9):523-34. PubMed ID: 7341065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effective single and combined chemotherapeutic regimens as regards to antibiotic resistance patterns of methicillin-resistant Staphylococcus aureus (MRSA) in Japan].
    Watanabe A
    Nihon Rinsho; 1992 May; 50(5):1060-5. PubMed ID: 1507429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel semisynthetic derivative of antibiotic Eremomycin active against drug-resistant gram-positive pathogens including Bacillus anthracis.
    Maples KR; Wheeler C; Ip E; Plattner JJ; Chu D; Zhang YK; Preobrazhenskaya MN; Printsevskaya SS; Solovieva SE; Olsufyeva EN; Heine H; Lovchik J; Lyons CR
    J Med Chem; 2007 Jul; 50(15):3681-5. PubMed ID: 17608397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection model.
    Huang V; Rybak MJ
    Antimicrob Agents Chemother; 2005 Jan; 49(1):302-8. PubMed ID: 15616309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis.
    Callegan MC; Engel LS; Hill JM; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1033-7. PubMed ID: 8125714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transconjunctival orbital invasion by methicillin-resistant Staphylococcus aureus.
    Brown SM; Raflo GT; Fanning WL
    Arch Ophthalmol; 2009 Jul; 127(7):941-2. PubMed ID: 19597122
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of vancomycin plus tobramycin as antiperitonitis regimen for patients on CAPD.
    Vargemezis V; Thodis E; Pasadakis P; Martinis G; Kousta E
    Adv Perit Dial; 1990; 6():123-5. PubMed ID: 1982788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Netilmicin and tobramycin: comparative evaluation of pharmacokinetics, nephrotoxicity, and therapeutic efficacy in animal studies (author's transl)].
    Marre R; Abraham M; Freiesleben H; Sack K
    Arzneimittelforschung; 1979; 29(6):940-5. PubMed ID: 582788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental study of histamine-liberating properties of eremomycin].
    Filippos'iants ST; Shevniuk LA
    Antibiot Khimioter; 1989 Mar; 34(3):209-12. PubMed ID: 2473716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin enhancement of experimental tobramycin nephrotoxicity.
    Wood CA; Kohlhepp SJ; Kohnen PW; Houghton DC; Gilbert DN
    Antimicrob Agents Chemother; 1986 Jul; 30(1):20-4. PubMed ID: 3752981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hospital epidemic caused by a methicillin-, gentamycin- and tobramycin-resistant Staphylococcus aureus].
    Geroulanos S; Bühler M; Grehn M; Largiadèr F
    Helv Chir Acta; 1988 Apr; 54(6):771-6. PubMed ID: 3403292
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.